Newsfiscal.ai
Minerva Neurosciences to Host In-Person KOL Event to Discuss Roluperidone for Negative Symptoms of Schizophrenia
· Published
Article summary
Minerva Neurosciences announced it will host an in-person and virtual event on November 12, 2026, featuring management and key opinion leaders to discuss the clinical opportunity for roluperidone.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…